Drug Epinephrine

Manufacturing

EpiPen rival Kaléo snapped up in $310M deal

EpiPen rival Kaléo was acquired in a $310 million deal by Marathon Asset Management.
Joseph Keenan Nov 30, 2021 9:35am

Meet Neffy, the kid-friendly epinephrine nasal spray from ARS

Sep 3, 2021 11:27am

Aquestive advances oral epinephrine plan after clearing phase 1

Mar 30, 2021 9:20am

Novartis bolsters Symjepi rollout amid EpiPen shortage

Jul 10, 2019 9:12am

Novartis launches EpiPen challenger at double-digit discount

Jan 17, 2019 10:20am

Novartis, Adamis keep swinging at EpiPen with new Symjepi dose

Sep 28, 2018 11:06am